This week, we challenged your medtech market knowledge with questions pulled straight from Compass. 𝙉𝙤𝙬 𝙞𝙩’𝙨 𝙩𝙞𝙢𝙚 𝙩𝙤 𝙧𝙚𝙫𝙚𝙖𝙡 𝙩𝙝𝙚 𝙖𝙣𝙨𝙬𝙚𝙧𝙨! Here’s another look at the questions we asked throughout the week. Scroll through the carousel to see the results. Visit ls-intel․com/data and start your paid subscription today.
Market Intelligence, by LSI
Market Research
Huntington Beach, California 2,996 followers
We transform seas of diverse, proprietary data into Medtech Market Intelligence 📊
About us
In a world overrun with information, finding the insights you actually need is like finding a needle in a haystack. Where will my products and services have the most impact? What do I need to know about my market and customers to inform strategy? And most importantly, how do I get defensible answers from billions of data points? With Compass, we transform seas of diverse, proprietary data into Medtech Market Intelligence. For nearly two decades, we’ve helped the world’s most successful Medtech, Life Science, and Professional Services organizations de-risk their biggest strategic decisions and grow their businesses, faster. We take the headache out of finding trusted data and insights, so you can serve your customers with confidence. We provide syndicated and custom Medtech Market Intelligence solutions for clients who build Medical Devices & Digital Health products and offer Consulting & Professional Services for the healthcare industry. From Medtronic to McKinsey & Co., clients trust us to help with: • Medtech product development • Corporate & go-to-market strategy • Business development & sales enablement • Client projects & services Our Medtech Market Intelligence solutions are powered by LSI. LSI's ecosystem of independent research and analysis, curated partnering events, and digital media has made LSI a trusted partner for Medtech innovation and investment worldwide. In 2024, LSI supported alumni of its Emerging Medtech Summits in the USA and Europe in raising over $2.67 Billion in capital. To learn more and schedule a demo of our Medtech Market Intelligence solutions, schedule a demo with us at: [https://calendly.com/nick-lsi].
- Website
-
https://www.lifesciencemarketresearch.com/compass
External link for Market Intelligence, by LSI
- Industry
- Market Research
- Company size
- 11-50 employees
- Headquarters
- Huntington Beach, California
- Type
- Privately Held
- Founded
- 2006
- Specialties
- Medtech, Medical Devices, Market Intelligence, Market Research, Competitive Intelligence, Data, Data Analysis, Venture Capital, Consulting, Surgical Procedure Volumes, Oncology, Neurology, Orthopedics, Cardiology, Robotics, Digital Surgery, and Diagnostics
Locations
-
Primary
Get directions
17011 Beach Blvd
Suite 500
Huntington Beach, California 92647, US
Employees at Market Intelligence, by LSI
Updates
-
Nicholas Talamantes and our Market Intelligence team closed out LSI Europe ’25 with a new Market Dive on Surgical Robotics. It was standing-room only, and every attendee walked away with the full presentation deck. Our Surgical Robotics Market Dive covers fundraising trends, key investors, and emerging segments. Schedule a Compass demo with Sina Saffari-Kermani and receive the full deck immediately after your call.
-
-
MALCOVA is utilizing proprietary computed tomography technology to provide a safe, comfortable, and effective imaging solution for the early detection and diagnosis of breast cancer, particularly in women with dense breasts. This technology is at the heart of a three-pronged approach that leverages the company’s advances in hardware, AI-based software, and patient-surrogate phantoms to yield a significant paradigm shift in the way breast cancer is detected and treated. MALCOVA Compass Profile Highlights: • Key Executives: Tara Ghazi, PhD, Peymon Ghazi • Grants from National Cancer Institute, National Science Foundation, National Institute of Health • Currently raising a $2M Seed round • Clinical study at Yale University begins in the coming year • Selected to present at LSI USA ‘26 Company profiles contain proprietary insights from LSI events and Market Intelligence. Full profiles available in Compass.
-
-
Market Intelligence, by LSI reposted this
Fall is officially here. Perhaps poetically, we are also seeing a cooling in deal flow in our Compass platform. Here are just a few of the deals from this past week in medtech: Nalu Medical, Inc. – Thomas A. West 𝗥𝗮𝗶𝘀𝗲 𝗔𝗺𝗼𝘂𝗻𝘁: $50M Funding 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆: Battery-free neurostimulation technology to treat chronic neuropathic pain 𝗜𝗻𝘃𝗲𝘀𝘁𝗼𝗿𝘀: Trinity Capital 𝘞𝘩𝘺 𝘐𝘵 𝘔𝘢𝘵𝘵𝘦𝘳𝘴: 𝘋𝘳𝘶𝘨 𝘵𝘩𝘦𝘳𝘢𝘱𝘺 𝘳𝘦𝘮𝘢𝘪𝘯𝘴 𝘵𝘩𝘦 𝘴𝘵𝘢𝘯𝘥𝘢𝘳𝘥 𝘰𝘧 𝘤𝘢𝘳𝘦 𝘧𝘰𝘳 𝘵𝘩𝘦 7-10% 𝘰𝘧 𝘢𝘥𝘶𝘭𝘵𝘴 𝘪𝘯 𝘵𝘩𝘦 𝘜𝘚 𝘸𝘪𝘵𝘩 𝘤𝘩𝘳𝘰𝘯𝘪𝘤 𝘯𝘦𝘶𝘳𝘰𝘱𝘢𝘵𝘩𝘪𝘤 𝘱𝘢𝘪𝘯. 𝘏𝘰𝘸𝘦𝘷𝘦𝘳, 𝘤𝘰𝘮𝘣𝘪𝘯𝘢𝘵𝘪𝘰𝘯 𝘵𝘩𝘦𝘳𝘢𝘱𝘪𝘦𝘴 𝘸𝘪𝘵𝘩 𝘯𝘰𝘯-𝘱𝘩𝘢𝘳𝘮𝘢𝘭𝘰𝘨𝘪𝘤𝘢𝘭 𝘪𝘯𝘵𝘦𝘳𝘷𝘦𝘯𝘵𝘪𝘰𝘯𝘴 𝘢𝘳𝘦 𝘰𝘧𝘵𝘦𝘯 𝘳𝘦𝘲𝘶𝘪𝘳𝘦𝘥 𝘵𝘰 𝘪𝘮𝘱𝘳𝘰𝘷𝘦 𝘰𝘶𝘵𝘤𝘰𝘮𝘦𝘴 𝘪𝘯 𝘵𝘩𝘦𝘴𝘦 𝘱𝘢𝘵𝘪𝘦𝘯𝘵𝘴. 𝘛𝘩𝘦 𝘣𝘢𝘵𝘵𝘦𝘳𝘺-𝘧𝘳𝘦𝘦, 𝘮𝘪𝘯𝘪𝘢𝘵𝘶𝘳𝘪𝘻𝘦𝘥 𝘪𝘮𝘱𝘭𝘢𝘯𝘵 𝘳𝘦𝘱𝘳𝘦𝘴𝘦𝘯𝘵𝘴 𝘢 𝘥𝘦𝘷𝘪𝘢𝘵𝘪𝘰𝘯 𝘧𝘳𝘰𝘮 𝘭𝘢𝘳𝘨𝘦𝘳 𝘪𝘮𝘱𝘭𝘢𝘯𝘵𝘢𝘣𝘭𝘦 𝘥𝘦𝘷𝘪𝘤𝘦𝘴 𝘵𝘩𝘢𝘵 𝘩𝘢𝘷𝘦 𝘩𝘪𝘴𝘵𝘰𝘳𝘪𝘤𝘢𝘭𝘭𝘺 𝘣𝘦𝘦𝘯 𝘶𝘵𝘪𝘭𝘪𝘻𝘦𝘥 𝘵𝘰 𝘮𝘢𝘯𝘢𝘨𝘦 𝘱𝘢𝘵𝘪𝘦𝘯𝘵𝘴 𝘸𝘪𝘵𝘩 𝘤𝘩𝘳𝘰𝘯𝘪𝘤 𝘱𝘢𝘪𝘯. VESTECK, Inc – Joseph W. Rafferty 𝗥𝗮𝗶𝘀𝗲 𝗔𝗺𝗼𝘂𝗻𝘁: $2M Grant 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆: Proprietary catheter sutures to prevent endovascular aortic repair grafts from migrating and leaking 𝗜𝗻𝘃𝗲𝘀𝘁𝗼𝗿𝘀: NIH (National Heart, Lung, and Blood Institute) 𝘞𝘩𝘺 𝘐𝘵 𝘔𝘢𝘵𝘵𝘦𝘳𝘴: 𝘐𝘵 𝘪𝘴 𝘦𝘴𝘵𝘪𝘮𝘢𝘵𝘦𝘥 𝘵𝘩𝘢𝘵 20-50% 𝘰𝘧 𝘢𝘭𝘭 𝘦𝘯𝘥𝘰𝘷𝘢𝘴𝘤𝘶𝘭𝘢𝘳 𝘢𝘰𝘳𝘵𝘪𝘤 𝘳𝘦𝘱𝘢𝘪𝘳 𝘱𝘳𝘰𝘤𝘦𝘥𝘶𝘳𝘦𝘴 𝘦𝘹𝘱𝘦𝘳𝘪𝘦𝘯𝘤𝘦 𝘴𝘰𝘮𝘦 𝘵𝘺𝘱𝘦 𝘰𝘧 𝘦𝘯𝘥𝘰𝘭𝘦𝘢𝘬. 𝘚𝘪𝘮𝘪𝘭𝘢𝘳𝘭𝘺, 5-10% 𝘰𝘧 𝘱𝘳𝘰𝘤𝘦𝘥𝘶𝘳𝘦𝘴 𝘦𝘹𝘱𝘦𝘳𝘪𝘦𝘯𝘤𝘦 𝘮𝘪𝘨𝘳𝘢𝘵𝘪𝘰𝘯. 𝘉𝘰𝘵𝘩 𝘤𝘰𝘮𝘱𝘭𝘪𝘤𝘢𝘵𝘪𝘰𝘯𝘴 𝘮𝘢𝘵𝘦𝘳𝘪𝘢𝘭𝘪𝘻𝘦 𝘵𝘩𝘰𝘶𝘴𝘢𝘯𝘥𝘴 𝘰𝘧 𝘥𝘰𝘭𝘭𝘢𝘳𝘴 𝘪𝘯 𝘤𝘰𝘴𝘵-𝘣𝘶𝘳𝘥𝘦𝘯, 𝘯𝘰𝘵 𝘵𝘰 𝘮𝘦𝘯𝘵𝘪𝘰𝘯 𝘳𝘪𝘴𝘬 𝘰𝘧 𝘢𝘯𝘦𝘶𝘳𝘺𝘴𝘮 𝘳𝘶𝘱𝘵𝘶𝘳𝘦. INBRAIN Neuroelectronics – Carolina Aguilar 𝗥𝗮𝗶𝘀𝗲 𝗔𝗺𝗼𝘂𝗻𝘁: Undisclosed 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆: Graphene core technology for the field of neuroelectronic therapies (i.e. neuromodulation) 𝗞𝗲𝘆 𝗗𝗲𝘁𝗮𝗶𝗹𝘀: Mayo Clinic know-how collaboration agreement 𝘞𝘩𝘺 𝘐𝘵 𝘔𝘢𝘵𝘵𝘦𝘳𝘴: 𝘎𝘳𝘢𝘱𝘩𝘦𝘯𝘦 𝘢𝘯𝘥 𝘰𝘵𝘩𝘦𝘳 𝘯𝘢𝘯𝘰𝘮𝘢𝘵𝘦𝘳𝘪𝘢𝘭𝘴 𝘢𝘳𝘦 𝘦𝘹𝘵𝘳𝘦𝘮𝘦𝘭𝘺 𝘱𝘳𝘰𝘮𝘪𝘴𝘪𝘯𝘨 𝘧𝘰𝘳 𝘧𝘶𝘵𝘶𝘳𝘦, 𝘶𝘭𝘵𝘳𝘢-𝘵𝘩𝘪𝘯, 𝘩𝘪𝘨𝘩-𝘤𝘩𝘢𝘯𝘯𝘦𝘭-𝘤𝘰𝘶𝘯𝘵 𝘉𝘊𝘐𝘴. 𝘛𝘩𝘪𝘴 𝘤𝘰𝘭𝘭𝘢𝘣𝘰𝘳𝘢𝘵𝘪𝘰𝘯 𝘴𝘦𝘦𝘬𝘴 𝘵𝘰 𝘢𝘤𝘤𝘦𝘭𝘦𝘳𝘢𝘵𝘦 𝘵𝘩𝘦 𝘥𝘦𝘷𝘦𝘭𝘰𝘱𝘮𝘦𝘯𝘵 𝘢𝘯𝘥 𝘤𝘰𝘮𝘮𝘦𝘳𝘤𝘪𝘢𝘭𝘪𝘻𝘢𝘵𝘪𝘰𝘯 𝘰𝘧 𝘐𝘕𝘉𝘙𝘈𝘐𝘕’𝘴 𝘵𝘦𝘤𝘩𝘯𝘰𝘭𝘰𝘨𝘺 𝘧𝘰𝘳 𝘢 𝘸𝘪𝘥𝘦 𝘳𝘢𝘯𝘨𝘦 𝘰𝘧 𝘯𝘦𝘶𝘳𝘰𝘭𝘰𝘨𝘪𝘤𝘢𝘭-𝘳𝘦𝘭𝘢𝘵𝘦𝘥 𝘥𝘪𝘴𝘰𝘳𝘥𝘦𝘳𝘴. 𝘛𝘩𝘦 𝘔𝘢𝘺𝘰 𝘊𝘭𝘪𝘯𝘪𝘤’𝘴 𝘴𝘶𝘱𝘱𝘰𝘳𝘵 𝘳𝘦𝘱𝘳𝘦𝘴𝘦𝘯𝘵𝘴 𝘢 𝘴𝘪𝘨𝘯𝘪𝘧𝘪𝘤𝘢𝘯𝘵 𝘤𝘰𝘭𝘭𝘢𝘣𝘰𝘳𝘢𝘵𝘪𝘰𝘯 𝘣𝘦𝘵𝘸𝘦𝘦𝘯 𝘢 𝘥𝘪𝘴𝘳𝘶𝘱𝘵𝘪𝘷𝘦 𝘯𝘦𝘸 𝘵𝘦𝘤𝘩𝘯𝘰𝘭𝘰𝘨𝘺 𝘢𝘯𝘥 𝘰𝘯𝘦 𝘰𝘧 𝘵𝘩𝘦 𝘭𝘦𝘢𝘥𝘪𝘯𝘨 𝘩𝘰𝘴𝘱𝘪𝘵𝘢𝘭𝘴 𝘪𝘯 𝘵𝘩𝘦 𝘸𝘰𝘳𝘭𝘥.
-
-
SV Health Investors is a specialist healthcare fund manager, investing across multiple stages and sectors. SV has an incredible track record with $3.7B in historical commitments and 75 IPOs/M&As to prove it. SV has managed diversified, multi-sector and multi-strategy healthcare private equity and venture capital funds. SV Health Investors’ portfolio includes companies like: • Alpheus Medical, Inc (Vijay Agarwal) • Perfuze (Wayne Allen) • SpectraWAVE, Inc. (Eman Namati) • Vibrato Medical, Inc. (Juliana Elstad) …among others Track medtech venture activity in real time with a paid subscription to Compass, LSI’s proprietary medtech discovery solution.
-
-
Efemoral Medical is a clinical stage startup developing a next-generation drug-eluting bioresorbable scaffold for the treatment of PAD. Using a minimally invasive procedure, the Efemoral Vascular Scaffold System is inserted into the leg and expanded inside the artery to restore a channel for blood flow to the foot. Recent company milestones include 28 patients enrolled in first-in-human trial, 15 issued patents, breakthrough device designation by FDA. Efemoral Medical Compass Highlights: • Key Executives: Christopher Haig, Lewis Schwartz • Based in California, United States with ~4 employees • Potential Acquirers: Medtronic, Boston Scientific, Abbott • Currently raising a $20M Series B round • Selected to present at LSI USA ‘26 Company profiles contain proprietary insights from LSI events and Market Intelligence. Full profiles available in Compass.
-